Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
In mammalian cells, the homeobox gene is divided into two major categories: the Hox gene and the heterogeneous Hox gene. The Hox gene is further divided into A, B, C, and D 4 families, and the heterogeneous Hox gene contains Meox, P ax, En. And other families. The heterozygous Hox gene plays an important role in the development of the posterior half of the higher body and the development of certain organs. Among them, Meox2 (M esoderm homeobox2) in the Meox family is involved in the negative regulation of vascular smooth muscle cells (VSMC) and cardiomyocyte cycle, and plays a role in the development of the cardiovascular system.
At different stages of mouse embryonic development, Meox2 expression was detected in the smooth muscle of the hindgut, the stomach, the posterior pharynx, the esophagus, the diaphragm, the smooth muscle of the bladder, and in the vasculature including the thymus and kidney. Meox2 is expressed in the aorta, vascular, saphenous vein, and vascular smooth muscle of the internal mammary artery in adults. In various tissues of adult rabbits, Meox2 is mainly expressed in the cardiovascular system. Compared with the expression levels of heart and other tissues, Meoox2 has the highest expression level in the descending thoracic aorta. Meox1 knockout mice have rib and vertebra fusion, but Meox2 knockout mice have defects in limb muscle development. Mice that knocked out Meox1 and Meox2 simultaneously showed a more severe phenotype, and most of the skeletal and midshaft bones could not form. This indicates that the Meox gene is essential for the normal development of the embryo.
Figure 1. Model of the signaling pathway for Ski modulation of myofibroblast phenotype.(Cunnington, R. H. , et al. 2014)
Meox2 and Vascular Smooth Muscle Cells
Platelet-derived growth factor (PDGF) and growth factors regulate the proliferation and differentiation of vascular smooth muscle cells (VSMC). VSMCs were isolated from rabbit aorta and cultured for 3 days in the absence of plasma, leaving them at rest. The VSMC was then stimulated by the addition of feta l bovine serum (FCS) or PDGF (as mitogen), and the mRNA level of Meox2 was rapidly down-regulated. Meox2 expression levels began to recover at 24 h after stimulation and returned to baseline levels 24 to 48 h after stimulation. After rapid growth of VSMC, cells were cultured in serum-free medium and the expression level of Meox2 increased five-fold within 24 h. These results indicate that Meox2 may have a function of regulation of G0/G1 conversion in the VSMC cycle. Other studies have shown that Meox2 has a significant correlation with the inhibition of VSM C proliferation after angioplasty and the up-regulation of cyclin-dependent kinase inhibitor (p21C IPI) expression. The inhibition of VSMC proliferation by Meox2 transitional expression is mediated by p21C IPI.
Meox2 and Angiogenesis
The regulation of vascular endothelial cells by Meox2 was studied. Northern blot, PCR, and cellular immunohistochemistry were used to detect the expression of Meox2 in normal vascular endothelial cells. Meox2 gene was transfected into umbilical vein endothelial cells (HUVEC) by replication-deficient adenovirus. The investigators then determined the proliferation of HUVEC, the uptake of 3H-thymidine, the expression of p21, and the formation of blood vessels after infection with different doses of virus. It was found that Meox2 strongly inhibited the proliferation of HUVEC, and the uptake of 3H-thymidine was also strongly inhibited by mitogen stimulation. Northern blot analysis revealed that the expression of p21 was up-regulated by 5 fold, the activity of the p21 promoter was activated 4 to 5 times, and the formation of blood vessels was significantly inhibited.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.